The Breast Cancer Predictive Genetic Testing Market is expected to register a CAGR of 11.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Breast Cancer Predictive Genetic Testing Market report covers analysis By Type (High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes); Application (Hospitals, Clinics, Other). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Breast Cancer Predictive Genetic Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Breast Cancer Predictive Genetic Testing Market Segmentation
Type- High Penetrant Genes
- Intermediate Penetrant Genes
- Low Penetrant Genes
- Hospitals
- Clinics
- Other
Strategic Insights
Breast Cancer Predictive Genetic Testing Market Growth Drivers- Rising Breast cancer cases globally: The rising prevalence of breast cancer worldwide increases the demand for predictive genetic testing. Market analysis reveals an increased awareness of genetic predispositions and developments in testing technologies as factors contributing to the increase in market size.
- Growth in Preventive healthcare measures: The growing trend in preventive healthcare drives the market upward, as individuals seek early detection options. Competitive analysis indicates the importance of predictive genetic testing in personalized healthcare strategies, which are gaining ground globally.
- Favorable Givernment Initiatives: Favorable government programs and reimbursement policies promote the usage of genetic testing. The market reports indicate that the market trends are greatly boosted by positive regulations and campaigns on awareness.
- Engage in Public health awareness: Public health awareness programs on early detection have boosted the adoption of predictive genetic tests. The market approach focuses on access and affordability.
- Demand for consumer-centric healthcare: The DTC genetic testing platforms are changing the rules of the game for this market. SWOT analysis indicates that there is an opportunity to focus on consumer-centric health care but challenges are regarding accuracy perceptions.
- Utilisation of Technology: Advances in AI and machine learning in genomics data analysis increase precision in predictive testing. Players who invest in such technologies will continue leading the market.
- Emphasis on Early detection: Growing knowledge of early detection and prevention fuels the demand for predictive genetic testing. Developed healthcare systems in North America generate the highest market share.
- AI in analyzing genetic conditions: The increased use of AI in testing genetic conditions increases accuracy and easy access, changing the dimensions of the industry.
- Market Expansion: Geographical regions such as Europe and Asia-Pacific have significant implementation potential. New growth opportunities are offered with the emergence of direct-to-consumer genetic testing kits, targeting proactive consumers across all geographies.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Breast Cancer Predictive Genetic Testing Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Breast Cancer Predictive Genetic Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Key companies of this market are: Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics.
Key future trends in this market are - Rising Awareness of Early Detection, Expansion of Direct-to-Consumer Testing, Advances in Genomic Data Analysis
The Breast Cancer Predictive Genetic Testing Market is estimated to witness a CAGR of 11.6% from 2023 to 2031.
The major factors driving the Market are: Rising breast cancer incidence, Shift to preventive healthcare, Government support and policies
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Breast Cancer Predictive Genetic Testing Market - By Type
1.3.2 Breast Cancer Predictive Genetic Testing Market - By Application
1.3.3 Breast Cancer Predictive Genetic Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. BREAST CANCER PREDICTIVE GENETIC TESTING - GLOBAL MARKET OVERVIEW
6.2. BREAST CANCER PREDICTIVE GENETIC TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HIGH PENETRANT GENES
7.3.1. Overview
7.3.2. High Penetrant Genes Market Forecast and Analysis
7.4. INTERMEDIATE PENETRANT GENES
7.4.1. Overview
7.4.2. Intermediate Penetrant Genes Market Forecast and Analysis
7.5. LOW PENETRANT GENES
7.5.1. Overview
7.5.2. Low Penetrant Genes Market Forecast and Analysis
8. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Breast Cancer Predictive Genetic Testing Market Overview
9.1.2 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.1.3 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.1.4 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.1.5 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Breast Cancer Predictive Genetic Testing Market
9.1.5.1.1 United States Breast Cancer Predictive Genetic Testing Market by Type
9.1.5.1.2 United States Breast Cancer Predictive Genetic Testing Market by Application
9.1.5.2 Canada Breast Cancer Predictive Genetic Testing Market
9.1.5.2.1 Canada Breast Cancer Predictive Genetic Testing Market by Type
9.1.5.2.2 Canada Breast Cancer Predictive Genetic Testing Market by Application
9.1.5.3 Mexico Breast Cancer Predictive Genetic Testing Market
9.1.5.3.1 Mexico Breast Cancer Predictive Genetic Testing Market by Type
9.1.5.3.2 Mexico Breast Cancer Predictive Genetic Testing Market by Application
9.2. EUROPE
9.2.1 Europe Breast Cancer Predictive Genetic Testing Market Overview
9.2.2 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.2.3 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.2.5 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Breast Cancer Predictive Genetic Testing Market
9.2.5.1.1 Germany Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.1.2 Germany Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.2 France Breast Cancer Predictive Genetic Testing Market
9.2.5.2.1 France Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.2.2 France Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.3 Italy Breast Cancer Predictive Genetic Testing Market
9.2.5.3.1 Italy Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.3.2 Italy Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.4 Spain Breast Cancer Predictive Genetic Testing Market
9.2.5.4.1 Spain Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.4.2 Spain Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.5 United Kingdom Breast Cancer Predictive Genetic Testing Market
9.2.5.5.1 United Kingdom Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.5.2 United Kingdom Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.6 Rest of Europe Breast Cancer Predictive Genetic Testing Market
9.2.5.6.1 Rest of Europe Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.6.2 Rest of Europe Breast Cancer Predictive Genetic Testing Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Overview
9.3.2 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Breast Cancer Predictive Genetic Testing Market
9.3.5.1.1 Australia Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.1.2 Australia Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.2 China Breast Cancer Predictive Genetic Testing Market
9.3.5.2.1 China Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.2.2 China Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.3 India Breast Cancer Predictive Genetic Testing Market
9.3.5.3.1 India Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.3.2 India Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.4 Japan Breast Cancer Predictive Genetic Testing Market
9.3.5.4.1 Japan Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.4.2 Japan Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.5 South Korea Breast Cancer Predictive Genetic Testing Market
9.3.5.5.1 South Korea Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.5.2 South Korea Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.6 Rest of Asia-Pacific Breast Cancer Predictive Genetic Testing Market
9.3.5.6.1 Rest of Asia-Pacific Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.6.2 Rest of Asia-Pacific Breast Cancer Predictive Genetic Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Overview
9.4.2 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Breast Cancer Predictive Genetic Testing Market
9.4.5.1.1 South Africa Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.1.2 South Africa Breast Cancer Predictive Genetic Testing Market by Application
9.4.5.2 Saudi Arabia Breast Cancer Predictive Genetic Testing Market
9.4.5.2.1 Saudi Arabia Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.2.2 Saudi Arabia Breast Cancer Predictive Genetic Testing Market by Application
9.4.5.3 U.A.E Breast Cancer Predictive Genetic Testing Market
9.4.5.3.1 U.A.E Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.3.2 U.A.E Breast Cancer Predictive Genetic Testing Market by Application
9.4.5.4 Rest of Middle East and Africa Breast Cancer Predictive Genetic Testing Market
9.4.5.4.1 Rest of Middle East and Africa Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.4.2 Rest of Middle East and Africa Breast Cancer Predictive Genetic Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Breast Cancer Predictive Genetic Testing Market Overview
9.5.2 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.5.3 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.5.5 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Breast Cancer Predictive Genetic Testing Market
9.5.5.1.1 Brazil Breast Cancer Predictive Genetic Testing Market by Type
9.5.5.1.2 Brazil Breast Cancer Predictive Genetic Testing Market by Application
9.5.5.2 Argentina Breast Cancer Predictive Genetic Testing Market
9.5.5.2.1 Argentina Breast Cancer Predictive Genetic Testing Market by Type
9.5.5.2.2 Argentina Breast Cancer Predictive Genetic Testing Market by Application
9.5.5.3 Rest of South and Central America Breast Cancer Predictive Genetic Testing Market
9.5.5.3.1 Rest of South and Central America Breast Cancer Predictive Genetic Testing Market by Type
9.5.5.3.2 Rest of South and Central America Breast Cancer Predictive Genetic Testing Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BREAST CANCER PREDICTIVE GENETIC TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET, KEY COMPANY PROFILES
12.1. ROCHE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. THERMO FISHER SCIENTIFIC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PERKINELMER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. QUEST DIAGNOSTICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MYRIAD GENETICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IVERSON GENETICS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CANCER GENETICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ONCOCYTE CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NEOGENOMICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INVITAE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Roche
2. Thermo Fisher Scientific
3. PerkinElmer
4. Quest Diagnostics
5. Myriad Genetics
6. Iverson Genetics
7. Cancer Genetics
8. OncoCyte Corporation
9. NeoGenomics
10. Invitae
11. Myriad Genetics, Inc.
12. Complete Genomics Incorporated
13. Ambry Genetics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For